Revolutionary Alzheimer’s drug, donanemab, shows potential in slowing cognitive decline, calls for cautious optimism due to potential side effects.
Latest in Neuroscience
-
-
BrainDepressionMedicineNeurosciencePsychiatrySciTech NewsStanford University
Stanford Researchers Discover Effective Depression Treatment by Correcting Abnormal Brain Signals
Stanford researchers discover that transcranial magnetic stimulation can reverse abnormal brain signals and serve as a biomarker for diagnosing depression.
-
Alzheimer'sBrainDementiaMedicineMITNeuroscienceSciTech News
MIT Researchers Reveal Insights into Tau Protein Tangles, Linked to Alzheimer’s Disease
MIT study unveils how Tau protein tangles, linked to Alzheimer’s, form and identifies a potential drug target.
-
BrainFearMedicineNeuroscienceSciTech NewsUniversity Of Tokyo
Unraveling the Neurological Underpinnings of Fear: Study Discovers Eye-Aversion Mechanism in Fruit Flies
Scientists uncover neurons in fruit fly brains that manage visual aversion to fear, potentially shedding light on human fear responses.
-
MedicineNeurosciencePerceptionSciTech NewsUniversity Of ExeterVision
Unveiling the Truth: The Role of Vision in Visual Illusions
New study challenges prevailing beliefs on visual illusions, attributing them to limitations in eyes and neural processing rather than complex …
-
BrainCognitionDevelopmentMedicineMemoryNeuroscienceSciTech News
Researchers Unveil Molecular Mechanisms Underlying Childhood Memory Development
by Manuel Costaby Manuel CostaScientists uncover molecular mechanisms behind childhood memory development, revealing the role of perineuronal net in memory transition.
-
BiologyGeneticsMedicineMultiple SclerosisNeuroscienceSciTech NewsYale University
Genetic Variant Linked to Accelerated Multiple Sclerosis Progression
by Amir Husseinby Amir HusseinGroundbreaking study identifies a genetic variant that accelerates multiple sclerosis progression, offering new avenues for treatment development.
-
BrainDepressionMedicineNeurosciencePharmacologySciTech NewsTokyo University Of ScienceUniversity Of Tsukuba
A Promising Depression Treatment: KNT-127 Offers Stress Relief and Minimal Side Effects
KNT-127: A promising depression treatment targeting stress and depressive symptoms with minimal side effects, according to recent mouse model research.
-
BrainLanguageMedicineNeuroscienceSciTech NewsUniversity Of Texas
Study Reveals Distinct Brain Areas for Music and Language Processing in Awake Musician during Brain Surgery
Study on awake musician during brain surgery reveals distinct brain areas for music and language processing, with different regions engaged …
-
BiologyBrainCell PressGeneticsMedicineNeuroscienceSchizophreniaSciTech News
Somatic Genetic Mutations Unveiled as Key Players in Schizophrenia Research Breakthrough
Groundbreaking study discovers link between somatic mutations & schizophrenia. NRXN1 & ABCB11 genes identified. Potential implications for treatment.